Articles From: Apricus Biosciences Announces Corporate Update and Third Quarter 2014 Financial Results Conference Call to Aptose Biosciences to Present at The Stifel 2014 Healthcare Conference


Company Recently Expanded Development Pipeline with U.S. In-License of Fispemifene SAN DIEGO, Nov.
Sign-up for Apricus Biosciences Announces Third Quarter 2014 Financial Results and Provides Corporate Update investment picks
SAN DIEGO, Dec.
Sign-up for Apricus Biosciences Appoints Brian T. Dorsey as Chief Development Officer investment picks
SAN DIEGO, Jan.
Sign-up for Apricus Biosciences to Present at Biotech Showcase 2015 investment picks
-- Apricus Funds Upfront License Fee and 2015 Phase 2b Development Cost with $10 Million Venture Debt Financing --
Sign-up for Apricus Expands Development Pipeline With the In-Licensing of U.S. Rights for Fispemifene, a Phase 2b Ready Asset, From Forendo Pharma Targeting Urological Conditions in Men investment picks
Arizona Public Service Co.
Sign-up for APS Seeks Additional Peaking Capacity investment picks
AptarGroup, Inc. (NYSE: ATR) announced today that it has entered into an agreement to repurchase approximately $250 million of its common stock under an accelerated share repurchase program (the “ASR program”). The ASR program is part of AptarGroup’s $350 million share repurchase authorization announced on October 30, 2014.
Sign-up for AptarGroup Announces $250 Million Accelerated Share Repurchase and Closes Private Placement of $475 Million investment picks
QUARTERLY CONFERENCE CALLS AptarGroup, Inc. (NYSE: ATR) announced the dates and times of quarterly conference calls for the year.
Sign-up for AptarGroup Announces Quarterly Conference Call and Annual Meeting Information investment picks
The Board of Directors of AptarGroup, Inc. (NYSE: ATR) today declared a quarterly cash dividend of $0.28 per share.
Sign-up for AptarGroup Declares Quarterly Dividend investment picks
The Board of Directors of AptarGroup, Inc. (NYSE: ATR) today declared a quarterly cash dividend of $0.28 per share.
Sign-up for AptarGroup Declares Quarterly Dividend investment picks
AptarGroup, Inc. (NYSE:ATR) today reported record third quarter revenues and earnings per share.
Sign-up for AptarGroup Reports Record Third Quarter Revenues and Earnings Per Share, Announces New $350 Million Share Repurchase Authorization investment picks
2014/12/15
Adds Commercial Expertise to Board SAN DIEGO and TORONTO , Dec.
Sign-up for Aptose Biosciences Announces Appointment of Dr. Erich Platzer to Board of Directors investment picks
2015/1/20
SAN DIEGO and TORONTO , Jan.
Sign-up for Aptose Biosciences Appoints Dr. Bradley Thompson to the Audit Committee investment picks
2015/1/20
Aptose Biosciences Appoints Dr.
Sign-up for Aptose Biosciences Appoints Dr. Bradley Thompson to the Audit Committee investment picks
2015/1/13
SAN DIEGO, California and TORONTO, Ontario , Jan.
Sign-up for Aptose Biosciences Doses First Patient in Phase 1b Clinical Study of APTO-253 in Relapsed or Refractory Hematological Malignancies investment picks
2015/1/13
Aptose Biosciences Doses First Patient in Phase 1b Clinical Study of APTO-253 in Relapsed or Refractory Hematological Malignancies Canada NewsWire SAN DIEGO, California and TORONTO, Ontario , Jan.
Sign-up for Aptose Biosciences Doses First Patient in Phase 1b Clinical Study of APTO-253 in Relapsed or Refractory Hematological Malignancies investment picks
APTO-253 In Vivo Data Demonstrate Single-Agent and Combination Activity in AML SAN FRANCISCO, CA , Dec.
Sign-up for Aptose Biosciences Presents APTO-253 Preclinical Data at 56th American Society of Hematology Annual Meeting investment picks
2014/11/4
SAN DIEGO and TORONTO , Nov.
Sign-up for Aptose Biosciences reports results for the four months ended September 30, 2014 investment picks
2014/10/30
SAN DIEGO and TORONTO , Oct.
Sign-up for Aptose Biosciences To Host Conference Call and Webcast For Four Month Interim Period Ended September 30, 2014 investment picks
2015/1/12
SAN DIEGO, CA and TORONTO , Jan.
Sign-up for Aptose Biosciences to Present at Biotech Showcase™ 2015 investment picks
2014/12/5
SAN DIEGO, CA and TORONTO , Dec.
Sign-up for Aptose Biosciences to Present at Oppenheimer & Co. 25th Annual Healthcare Conference investment picks
2014/11/17
SAN DIEGO and TORONTO , Nov.
Sign-up for Aptose Biosciences to Present at The Stifel 2014 Healthcare Conference investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Apricus Biosciences Announces Corporate Update and Third Quarter 2014 Financial Results Conference Call to Aptose Biosciences to Present at The Stifel 2014 Healthcare Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent